The correlation between 14 SNPs of VEGF-A, VEGFR-2, and HIF-1a with treatment efficacy and toxicity was examined in 54 patients receiving bevacizumab and sorafenib for recurrent glioblastoma. This evidence concerns the gene VEGFA and glioblastoma.